IP Library Granted Patent US 7,902,387
Granted Patent B2
US 7,902,387 · App. 12/153,446 · Granted Mar 8, 2011

Preparation of bile acids and intermediates thereof

Assignee: Kythera Biopharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,902,387
App. No.
12/153,446
Granted
Mar 8, 2011
Kind
B2
Abstract

Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.

Claims (27)

1. A method for preparing deoxycholic acid (DCA) or a pharmaceutically acceptable salt thereof:

said method comprising

(a) reacting 9α-hydroxyandrost-4-en-3,17-dione 1.0 with H 2 under hydrogenation conditions to form compound 1.1

(b) reacting compound 1.1 with acid to form compound 1.2

(c) reacting compound 1.2 with a reducing agent to form compound 1.3 or a mixture of 1.3 and 1.4

(d) reacting compound 1.3 with a two carbon olefination reagent under olefin forming conditions to form compound 1.5

(e) converting compound 1.5 to a compound of formula 1.6 wherein P is a protecting group

(f) reacting the compound of formula 1.6 with an alkylpropiolate of the formula CH≡CC(O)OR or an alkyl acrylate of the formula CH 2 ═CHC(O)OR, wherein R is alkyl, in the presence of a Lewis acid to form a compound of formula 1.7 wherein P is a protecting group, R is an alkyl, and the dashed line is a single or double bond;

(g) reacting the compound of formula 1.7 with H 2 under hydrogenation conditions to form a compound of formula 1.8 wherein P is a protecting group and R is alkyl

(h) reacting the compound of formula 1.8 with an oxidizing agent to form a compound of formula 1.9 wherein P is a protecting group and R is alkyl

(i) reacting the compound of formula 1.9 with H 2 under hydrogenation conditions to form a compound of formula 2.0 wherein P is a protecting group and R is alkyl

(j) reacting the compound of formula 2.0 with a reducing agent to form a compound of formula 2.1 wherein P is a protecting group and R is alkyl

(k) exposing the compound of formula 2.1 to deprotection and hydrolysis conditions to form deoxycholic acid or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 wherein the hydrogenation conditions of part (a) comprise a Pd/C catalyst.

3. The method of claim 1 wherein the acid of part (b) is a mineral acid.

4. The method of claim 3 wherein the mineral acid is H 2 SO 4 .

5. The method of claim 1 wherein the reducing agent of part (c) is LiAl(OtBu) 3 H.

6. The method of claim 1 wherein the two carbon olefination reagent of part (d) is Ph 3 PCH 2 CH 3 + Br − .

7. The method of claim 1 wherein the protecting group P of compound 1.6-2.1 is —C(O)CH 3 .

8. The method of claim 1 wherein the Lewis acid of part (f) is EtAlCl 2 .

9. The method of claim 1 wherein the alkylpropiolate or alkylacrylate is methylpropriolate or methylacrylate.

10. The method of claim 1 wherein the hydrogenation conditions of part (g) comprise a PtO 2 catalyst.

11. The method of claim 1 wherein the oxidizing agent of part (h) is CrO 3 .

12. The method of claim 1 wherein the hydrogenation conditions of part (i) comprises a Pd/C catalyst.

13. The method of claim 1 wherein the reducing agent of part (j) is LiAl(OtBu) 3 H.

14. The method of claim 1 wherein the deprotection and hydrolysis conditions of part (k) when P is —C(O)CH 3 comprise reacting compound 2.1 with an alkali metal hydroxide, alkali earth alkoxide, or a mixture of both.

15. The method of claim 1 wherein the deprotection and hydrolysis conditions of part (k) when P is —C(O)CH 3 comprise reacting compound 2.1 with LiOH.

Assignments (4)
MERGER AND CHANGE OF NAME Recorded Oct 25, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050834/0182 →
CHANGE OF NAME Recorded Oct 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050672/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2008
From: SAHOO, AKHILA KUMAR
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 022010/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2008
From: PRASAD, ACHAMPETA RATHAN; SWARINGEN, ROY A, JR.; REID, JOHN GREGORY; MORIARTY, ROBERT M
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 021444/0894 →
Priority Claims (1)
GB 0807615.0 · Apr 25, 2008 · national
Continuity (2)
Related Publication 20090270642A1 · Oct 29, 2009
Related Publication 20100179337A2 · Jul 15, 2010